Telehealth Adoption Boosts Demand: Medical Adhesives Market Thriving Amid Aging Population

The “Medical Adhesives Market, Size, Global Forecast 2023-2030, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis” report has been added to ResearchAndMarkets.com’s offering.

The global medical adhesives market is projected to achieve a significant milestone, with an estimated value of US$16.35 billion by the year 2030, according to this report.

Medical adhesives, versatile substances used in healthcare for wound closure, securing medical devices, and manufacturing additives for medical equipment, are gaining prominence as alternatives to traditional sutures and staples in various medical procedures, including dentistry and orthopedics.

Key Features of Medical Adhesives

Medical adhesives are characterized by their flexibility, non-toxic nature, and full ingredient transparency, ensuring patient safety and compliance with stringent healthcare standards. They are used in diverse applications, including tapes, dressings, electrodes, patches, and ostomy products. Surgical sealants, made from synthetic or natural materials, are often used in conjunction with sutures or staples to ensure complete closure of surgical incisions.

Market Growth Drivers

The rapid effectiveness of medical adhesives compared to traditional methods such as stitches is a key driver of market growth. Manufacturers are increasingly adopting cost-effective, easy-to-maintain, and eco-friendly solutions to gain a competitive edge. Technological advancements have led to the development of biocompatible and environmentally friendly surgical adhesives, which are now used in various medical applications, including device assembly and both internal and external medical uses.

Factors Contributing to Market Growth

  1. Cardiovascular Disease Epidemic: The global population is facing a crisis of unhealthy lifestyles, with a direct link to cardiovascular diseases. Medical adhesives are finding increased use in internal medical applications, such as cardiac surgery. Fibrin-based adhesives, with hemostatic properties, are witnessing substantial growth in cardiac surgery.
  2. Aging Population: The worldwide aging population is a significant driver of market expansion. The elderly are more susceptible to illnesses, providing a steady foundation for market growth in the coming years.
  3. Telehealth Adoption: The COVID-19 pandemic accelerated the adoption of telehealth solutions, increasing the demand for remote patient monitoring tools and wearable drug delivery systems. This trend has boosted the need for medical adhesives, which are crucial for securing these devices.

Segmentation and Key Findings

  • Resin Type: The acrylic segment is the fastest-growing in the medical adhesives market due to its exceptional bonding properties, versatility, and durability. It is ideal for various medical applications, including wound closures and medical device assembly.
  • Application: Dental adhesives lead the market due to their critical role in various dental procedures, driven by the demand for aesthetically pleasing dental work and advanced adhesive technology.
  • Technology: Water-based products are expected to dominate the market due to their biocompatibility, safety in medical devices, and eco-friendliness.

Regional Overview

The United States commands the largest market share in the global medical adhesives market, driven by a thriving healthcare sector, technological advancements, and stringent regulatory standards. India’s healthcare sector is also poised for significant growth, which will contribute to the expansion of the medical adhesives market in the country.

Market Segmentation

By Resin Type
1. Arcylic
2. Silicone
3. Polyurethane
4. Epoxy
5. Others

By Technology
1. Water-Based
2. Solvent-Based
3. Hot-Melt
4. Reactive
5. Others

By Application
1. Dental
2. Medical Device & Equipment
3. External
4. Internal
5. Others

By Region

1. North America
1.1 United States
1.2 Canada

2. Europe
2.1 France
2.2 Germany
2.3 Italy
2.4 Spain
2.5 United Kingdom
2.6 Belgium
2.7 Netherland
2.7 Netherland
2.8 Turkey

3. Asia Pacific
3.1 China
3.2 Japan
3.3 India
3.4 South Korea
3.5 Thailand
3.6 Malaysia
3.7 Indonesia
3.8 Australia
3.9 New Zealand

4. Latin America
4.1 Brazil
4.2 Mexico
4.3 Argentina

5. Middle East & Africa
5.1 South Africa
5.2 Saudi Arabia
5.3 UAE

6. Rest of the World

Key Players:
1. H.B. Fuller Company
2. Henkel AG & Co. KGaA
3. Avery Dennison Corporation
4. Ashland Global Holdings Inc.
5. The Dow Chemical Company
6. 3M Co
7. PPG Industries
8. Dupoint De Nemours, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/8guun7

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”